关注
Annalisa Mupo
Annalisa Mupo
Scientific Programme Manager
在 altoslabs.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia
K Tzelepis, H Koike-Yusa, E De Braekeleer, Y Li, E Metzakopian, ...
Cell reports 17 (4), 1193-1205, 2016
6972016
ArrayExpress update—trends in database growth and links to data analysis tools
G Rustici, N Kolesnikov, M Brandizi, T Burdett, M Dylag, I Emam, A Farne, ...
Nucleic acids research 41 (D1), D987-D990, 2012
4342012
Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome
R Paylor, B Glaser, A Mupo, P Ataliotis, C Spencer, A Sobotka, C Sparks, ...
Proceedings of the National Academy of Sciences 103 (20), 7729-7734, 2006
3562006
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
MWM Kühn, E Song, Z Feng, A Sinha, CW Chen, AJ Deshpande, ...
Cancer discovery 6 (10), 1166-1181, 2016
2492016
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts
A Mupo, M Seiler, V Sathiaseelan, A Pance, Y Yang, AA Agrawal, F Iorio, ...
Leukemia 31 (3), 720-727, 2017
1452017
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice
A Mupo, L Celani, O Dovey, JL Cooper, C Grove, R Rad, P Sportoletti, ...
Leukemia 27 (9), 1917-1920, 2013
1062013
Exploring death receptor pathways as selective targets in cancer therapy
M Russo, A Mupo, C Spagnuolo, GL Russo
Biochemical pharmacology 80 (5), 674-682, 2010
962010
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition
MM Dzama, M Steiner, J Rausch, D Sasca, J Schönfeld, K Kunz, ...
Blood, The Journal of the American Society of Hematology 136 (21), 2442-2456, 2020
912020
Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα
M Russo, R Palumbo, A Mupo, M Tosto, G Iacomino, A Scognamiglio, ...
Oncogene 22 (21), 3330-3342, 2003
842003
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia
OM Dovey, JL Cooper, A Mupo, CS Grove, C Lynn, N Conte, RM Andrews, ...
Blood, The Journal of the American Society of Hematology 130 (17), 1911-1922, 2017
792017
Tbx1 regulates Vegfr3 and is required for lymphatic vessel development
L Chen, A Mupo, T Huynh, S Cioffi, M Woods, C Jin, W McKeehan, ...
Journal of Cell Biology 189 (3), 417-424, 2010
752010
Genetic modification of primary human B cells to model high-grade lymphoma
R Caeser, M Di Re, JA Krupka, J Gao, M Lara-Chica, JML Dias, SL Cooke, ...
Nature Communications 10 (1), 4543, 2019
702019
Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients
M Russo, C Spagnuolo, S Volpe, A Mupo, I Tedesco, GL Russo
British journal of cancer 103 (5), 642-648, 2010
642010
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications
P Sportoletti, E Varasano, R Rossi, A Mupo, E Tiacci, G Vassiliou, ...
Leukemia 29 (2), 269-278, 2015
532015
Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants
F Vitelli, Z Zhang, T Huynh, A Sobotka, A Mupo, A Baldini
Developmental biology 295 (2), 559-570, 2006
522006
Vitamin D receptor controls cell stemness in acute myeloid leukemia and in normal bone marrow
E Paubelle, F Zylbersztejn, TT Maciel, C Carvalho, A Mupo, M Cheok, ...
Cell reports 30 (3), 739-754. e4, 2020
392020
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression
H Yun, N Narayan, S Vohra, G Giotopoulos, A Mupo, P Madrigal, D Sasca, ...
Nature genetics 53 (10), 1443-1455, 2021
292021
A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193–1205
K Tzelepis, H Koike-Yusa, E De Braekeleer, Y Li, E Metzakopian, ...
J. CELREP 79, 2016
182016
Biochemical and functional characterization of protein kinase CK2 in ascidian Ciona intestinalis oocytes at fertilization: Cloning and sequence analysis of cDNA for α and β …
GL Russo, M Tosto, A Mupo, I Castellano, A Cuomo, E Tosti
Journal of Biological Chemistry 279 (31), 33012-33023, 2004
182004
Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer Discov. 2016; 6: 1166–1181. doi: 10.1158/2159-8290
MWM Kühn, E Song, Z Feng, A Sinha, CW Chen, AJ Deshpande, ...
CD-16-0237.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
11
系统目前无法执行此操作,请稍后再试。
文章 1–20